Effect of ZnO-doped magnesium phosphate cements on osteogenic differentiation of mBMSCs in vitro

J Appl Biomater Funct Mater. 2022 Jan-Dec:20:22808000221136369. doi: 10.1177/22808000221136369.

Abstract

The insufficient osteogenesis of magnesium phosphate cements (MPCs) limits its further application. It is significant to develop a bioactive MPC with osteogenic properties. In this work, MPCs were reinforced by zinc oxide nanoparticles (ZnO-NPs). The composition, microstructure, setting time, compressive strength and degradation of ZnO-NPs/MPCs (ZNMPCs) were evaluated. The results showed that the setting times of MPCs were prolonged from 8.2 to 25.3 min (5.0ZNMPC). The exothermic temperatures were reduced from 45.8 ± 0.4℃ (MPCs) to 39.3 ± 0.5℃ (1.0ZNMPC). The compressive strength of ZNMPC composite cement with 1 wt. % ZnO-NPs (1.0ZNMPC) was the highest (42.9 MPa) among all the composite cements. Furthermore, the ZNMPCs were cultured with mouse bone marrow mesenchymal stem cells (mBMSCs). The results yielded that the ZNMPCs exhibited good cytocompatibility with enhanced differentiation, proliferation, and mineralization on mBMSCs, and it also pronouncedly elevated the expressions of genes and proteins involving osteogenesis. These findings suggested that ZNMPCs could drive the differentiation toward osteogenesis and mineralization of mBMSCs, providing a simple way to the MPC with enhanced osteogenesis for further orthopedic applications.

Keywords: Magnesium phosphate cement; ZnO-NPs; cytocompatibility; mineralization; osteogenesis.

MeSH terms

  • Animals
  • Magnesium Compounds / chemistry
  • Magnesium Compounds / pharmacology
  • Mesenchymal Stem Cells*
  • Mice
  • Osteogenesis
  • Zinc Oxide* / pharmacology

Substances

  • magnesium phosphate
  • Zinc Oxide
  • Magnesium Compounds